Unasyn (Ampicillin-Sulbactam) Intramuscular Dosing
For adults, Unasyn IM dosing is 1.5 g to 3 g (ampicillin 1-2 g plus sulbactam 0.5-1 g) every 6 hours, with a maximum sulbactam dose of 4 g per day. 1
Adult IM Dosing
The standard intramuscular regimen for adults with normal renal function is:
- Dose range: 1.5 g to 3 g every 6 hours
- This represents the combined ampicillin + sulbactam content (2:1 ratio)
- Maximum sulbactam: Do not exceed 4 g per day 1
Renal Dose Adjustments
Dosing frequency must be reduced in renal impairment, as both ampicillin and sulbactam are primarily renally cleared 1, 2:
- CrCl ≥30 mL/min: 1.5-3 g every 6-8 hours
- CrCl 15-29 mL/min: 1.5-3 g every 12 hours
- CrCl 5-14 mL/min: 1.5-3 g every 24 hours 1
For hemodialysis patients, administer doses after dialysis since approximately 35% of ampicillin and 45% of sulbactam are removed during a 4-hour treatment 2.
Pediatric IM Dosing
The safety and efficacy of Unasyn administered via intramuscular injection in pediatric patients have not been established. 1
For pediatric patients requiring Unasyn, the IV route is recommended:
- Dose: 300 mg/kg/day (total ampicillin + sulbactam) divided every 6 hours
- This corresponds to 200 mg/kg/day ampicillin + 100 mg/kg/day sulbactam
- Children ≥40 kg: Use adult dosing (maximum sulbactam 4 g/day) 1
The FDA label explicitly states that IM administration in pediatric patients lacks established safety and efficacy data 1. Multiple guidelines reference IV dosing for children but do not provide IM recommendations 3, 4.
Pharmacokinetic Considerations
Important clinical caveat: IM injection of Unasyn is painful 5, 6. After IM administration of 0.5/1.0 g, peak concentrations are achieved with a half-life of approximately 1.2 hours for both components 7. The drugs distribute extensively into extracellular fluids with volumes of distribution around 22-25 liters 7.
Renal clearance exceeds glomerular filtration rate for both drugs, indicating active tubular secretion 7. This explains why renal impairment dramatically affects drug clearance—terminal half-lives more than double in severe renal failure compared to normal function 2, 8.
Clinical Context from Guidelines
While the FDA label provides the definitive dosing, guidelines show Unasyn used primarily IV in serious infections. For endocarditis caused by HACEK organisms, the regimen is 12 g/24 hours IV in 4 divided doses (3 g every 6 hours) for 4 weeks 5, 9. For intra-abdominal infections in children, 200 mg/kg/day ampicillin component IV divided every 6 hours is recommended 3.
The IM route appears reserved for less severe infections where IV access is problematic, though pain at injection site remains a significant limitation 6.